Janet B. McGill

机构：Washington University in St. Louis · ORCID：0000-0002-6228-6521

发表论文 420 篇 · 总被引 29178 次 · h-index 86

代表论文

• Finerenone in Type 1 Diabetes and Chronic Kidney Disease (2026 · New England Journal of Medicine · 被引 27)
• Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both (2025 · Journal of the American College of Cardiology · 被引 6)
• Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive Review (2026 · Diabetes Technology & Therapeutics · 被引 3)
• Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review (2026 · Diabetes Technology & Therapeutics · 被引 3)
• Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both (2025 · Journal of the American Society of Nephrology · 被引 3)
• Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone (2026 · Journal of the American Society of Nephrology · 被引 2)